The Valley Desk

Clinical trial reportJournal of the American Academy of DermatologyPublished

Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of the American Academy of Dermatology
Published
Subject terms
Skin; Humans; Dermatitis, Atopic; Eczema; Leg Dermatoses; Boron Compounds; Ointments; Treatment Outcome; Double-Blind Method; Bridged Bicyclo Compounds, Heterocyclic; Proof of Concept Study; Pruritus
PubMed ID
38340127
Added to directory
Source checked

Report a correction or request removal